iBio - Die Impfstoffmaschine (Seite 231)
eröffnet am 16.03.11 21:21:25 von
neuester Beitrag 15.04.24 13:23:03 von
neuester Beitrag 15.04.24 13:23:03 von
Beiträge: 18.249
ID: 1.164.726
ID: 1.164.726
Aufrufe heute: 2
Gesamt: 2.207.100
Gesamt: 2.207.100
Aktive User: 0
ISIN: US4510337086 · WKN: A3E2GR · Symbol: IBIO
1,7600
USD
+3,53 %
+0,0600 USD
Letzter Kurs 02:04:00 NYSE Arca
Neuigkeiten
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,9000 | +59,66 | |
| 0,5922 | +44,44 | |
| 7,3500 | +43,84 | |
| 11,690 | +40,84 | |
| 0,7000 | +36,69 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 10,110 | -13,44 | |
| 8,2200 | -13,47 | |
| 7,6100 | -17,20 | |
| 1,6100 | -18,27 | |
| 2,1200 | -21,77 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 68.104.379 von aaahhh am 07.05.21 15:41:0320% für so ein News ist doch mehr als genug.
201 eingestellt und wieder auf 202 warten. 203 kommt wohl auch noch.
201 eingestellt und wieder auf 202 warten. 203 kommt wohl auch noch.
Antwort auf Beitrag Nr.: 68.104.016 von Schlood am 07.05.21 15:23:13Die news kommen nach wie vor zu ungünstigen Zeiten. Die letzten beiden in dem after hour Handel, die davor im pre Handel. Beides sorgt für einen unruhigen Handel mit meist einem Abverkauf des plus und Gewinnmitnahmen. Außerdem wird meist ein unnötiges gap gerissen. Schön für Trader, aber nicht gut für eine kontinuierliche Kursentwicklung! Das sollten sie mal überdenke für die Zukunft, das ist suboptimal.
Gruß aaahhh
Gruß aaahhh
$IBIO it’s official.
Literally zero short shares available:
🤔 👍
Literally zero short shares available:
🤔 👍
Wir könnten den DIP heute doch mal einfach ausfallen lassen und direkt durchstarten 😇.
Antwort auf Beitrag Nr.: 68.103.326 von aaahhh am 07.05.21 14:51:312000 Dollar pro Monat für Lebensversicherung.
Trading Spotlight
Antwort auf Beitrag Nr.: 68.103.122 von jarek_1 am 07.05.21 14:39:11Hoffentlich direct nach öffnen, ein dip gibt und danach 📈 bis 2usd heute.
Antwort auf Beitrag Nr.: 68.098.172 von aaahhh am 07.05.21 10:34:29T. Isett hat seinen Vertrag um 2 Jahre verlängert, dazu das 8K:
On April 30, 2021, iBio, Inc. (the “Company”) entered into a new employment agreement, dated as of April 30, 2021, with Thomas F. Isett, the Company’s Chief Executive
Officer (the “New Employment Agreement”) in order to further enhance corporate governance and better align its compensation arrangements with current best practices. The
New Employment Agreement, which was approved by the Company’s Compensation Committee, replaces in its entirety the Amended and Restated Executive Employment
Agreement, dated as of April 21, 2020, by and between Mr. Isett and the Company (the “Prior Agreement”) and removed certain legacy contractual obligations, including an
uncapped transaction bonus of 4.5% to be paid in connection with a Change of Control (as defined in the Prior Agreement), which were not viewed by the Company’s
Compensation Committee as best governance practices or as being aligned with the Company’s goals.
Pursuant to the terms of the New Employment Agreement, Mr. Isett will serve as the Company’s Chief Executive Officer for a term of two years, subject to extensions for oneyear periods. Mr. Isett will receive an annual base salary of $650,000 and he is still eligible to receive a target bonus of 60% of his base salary based upon the Compensation
Committee’s assessment of his performance and the performance of the Company during the prior fiscal year.
In addition, pursuant to the terms of the New Employment Agreement, the Company issued Mr. Isett an award of nonqualified stock options to purchase 3,000,000 shares of the
Company’s common stock (the “Option Shares”), which will be issued pursuant to the Company’s 2020 Omnibus Equity Incentive Plan (the “Plan”). The Option Shares vest as
follows: 25% of the Option Shares granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the Option
Shares will vest for each additional three (3) months of employment, subject to the conditions of the Plan and the stock option grant agreement. The New Employment
Agreement also provides that the Compensation Committee will establish certain performance criteria and thereafter Mr. Isett will receive a grant of 5,000,000 performance
restricted stock units (“RSUs”), which will also vest subject to achievement of pre-defined performance criteria to be established by the Compensation Committee.
https://d1io3yog0oux5.cloudfront.net/sec/0001104659-21-0624…
Gruß aaahhh
On April 30, 2021, iBio, Inc. (the “Company”) entered into a new employment agreement, dated as of April 30, 2021, with Thomas F. Isett, the Company’s Chief Executive
Officer (the “New Employment Agreement”) in order to further enhance corporate governance and better align its compensation arrangements with current best practices. The
New Employment Agreement, which was approved by the Company’s Compensation Committee, replaces in its entirety the Amended and Restated Executive Employment
Agreement, dated as of April 21, 2020, by and between Mr. Isett and the Company (the “Prior Agreement”) and removed certain legacy contractual obligations, including an
uncapped transaction bonus of 4.5% to be paid in connection with a Change of Control (as defined in the Prior Agreement), which were not viewed by the Company’s
Compensation Committee as best governance practices or as being aligned with the Company’s goals.
Pursuant to the terms of the New Employment Agreement, Mr. Isett will serve as the Company’s Chief Executive Officer for a term of two years, subject to extensions for oneyear periods. Mr. Isett will receive an annual base salary of $650,000 and he is still eligible to receive a target bonus of 60% of his base salary based upon the Compensation
Committee’s assessment of his performance and the performance of the Company during the prior fiscal year.
In addition, pursuant to the terms of the New Employment Agreement, the Company issued Mr. Isett an award of nonqualified stock options to purchase 3,000,000 shares of the
Company’s common stock (the “Option Shares”), which will be issued pursuant to the Company’s 2020 Omnibus Equity Incentive Plan (the “Plan”). The Option Shares vest as
follows: 25% of the Option Shares granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the Option
Shares will vest for each additional three (3) months of employment, subject to the conditions of the Plan and the stock option grant agreement. The New Employment
Agreement also provides that the Compensation Committee will establish certain performance criteria and thereafter Mr. Isett will receive a grant of 5,000,000 performance
restricted stock units (“RSUs”), which will also vest subject to achievement of pre-defined performance criteria to be established by the Compensation Committee.
https://d1io3yog0oux5.cloudfront.net/sec/0001104659-21-0624…
Gruß aaahhh
na das sieht doch gut aus ob wir heute die 2 us sehen
Na, das wird doch nicht wieder ein Rohrkrepierer?😉
Durchsuchen
